Results

Janssen Pharmaceuticals Inc.

10/23/2020 | Press release | Distributed by Public on 10/23/2020 15:46

Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.